antibodies

An antiviral pill to treat COVID and reduce the risk of hospitalization and death in high-risk groups could be around the corner. Here’s why immunocompromised people have the most to gain.

Immunocompromised people tend not to gain the same protection from the COVID-19 vaccine as those with fully functioning immune systems. As a result, navigating the pandemic has been much more challenging for them. Meet one scientist studying this population and figuring out ways to help.